
Incendia Therapeutics
Operator of a novel therapeutics company intended to invent a class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The company designs a portfolio of drug candidates that in...
Valuation
$0
Share Price
N/A
Total Raised
$78.3M
Last Round
N/A